Molecular Signature Used To Predict Radiation Therapy Benefit Validated By Moffitt Cancer Center Researchers, Colleagues

Researchers at Moffitt Cancer Center, working with colleagues in Sweden, the Netherlands and Puerto Rico, have validated a radiosensitivity molecular signature that can lead to better radiation therapy decisions for treating patients with breast cancer. The results appeared in a recent issue of Clinical Cancer Research, a publication of the American Association for Cancer Research...

Leia toda a matéria clicando aqui!

Fonte: healthnews.com